Erectile Dysfunction

• 

  Subject Areas on Research

  • A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. 
  • A mouse model of hypercholesterolemia-induced erectile dysfunction. 
  • A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy. 
  • A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019. 
  • A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. 
  • A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. 
  • A prostaglandin E1 dose-response study in man. 
  • ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. 
  • An international comparison of the reliability and responsiveness of the Duke Health Profile for measuring health-related quality of life of patients treated with alprostadil for erectile dysfunction. 
  • An outcomes analysis of over 200 revision surgeries for penile prosthesis implantation: a multicenter study. 
  • Androgen deprivation therapy in prostate cancer: anticipated side-effects and their management. 
  • Assessing adverse events of postprostatectomy radiation therapy for prostate cancer: evaluation of outcomes in the Regione Emilia-Romagna, Italy. 
  • Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer. 
  • Association between preoperative erectile dysfunction and prostate cancer features--an analysis from the Duke Prostate Center Database. 
  • Bacterial biofilms and implantable prosthetic devices. 
  • Can a urologic nurse contribute to management of secondary impotence in an office setting? 
  • Candida albicans corpora abscess following penile prosthesis placement. 
  • Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men. 
  • Cholesterol feeding reduces vascular endothelial growth factor signaling in rabbit corporal tissues. 
  • Clarifying the Relative Impacts of Vascular and Nerve Injury That Culminate in Erectile Dysfunction in a Pilot Study Using a Rat Model of Prostate Irradiation and a Thrombopoietin Mimetic. 
  • Communication patterns in patients with erectile dysfunction and their partners. 
  • Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population. 
  • Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. 
  • Complications and postoperative events after cryosurgery for prostate cancer. 
  • Complications of Small-Carrion penile prosthesis. 
  • Construct validity of the PROMIS® sexual function and satisfaction measures in patients with cancer. 
  • Cross-sectional survey of long-term quality of life after radical perineal prostatectomy. 
  • Defining potency: a comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite. 
  • Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach. 
  • Does impotence improve after parathyroidectomy in men with primary hyperparathyroidism? 
  • Effects of nonlinear aerobic training on erectile dysfunction and cardiovascular function following radical prostatectomy for clinically localized prostate cancer. 
  • Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option. 
  • Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate. 
  • Erectile dysfunction in early, middle, and late adulthood: symptom patterns and psychosocial correlates. 
  • Erectile dysfunction in men under 40: etiology and treatment choice. 
  • Erectile function outcome reporting after clinically localized prostate cancer treatment. 
  • Etiology of ejaculation and pathophysiology of premature ejaculation. 
  • Experience with the AMS 600 malleable penile prosthesis. 
  • External beam radiation therapy after radical prostatectomy: efficacy and impact on urinary continence. 
  • Factors predicting early and late phase decline of sexual health-related quality of life following radical prostatectomy. 
  • Feasibility study of an intensity-modulated radiation model for the study of erectile dysfunction. 
  • Fertility Related Quality of Life, Gonadal Function and Erectile Dysfunction in Male Partners of Couples with Unexplained Infertility. 
  • Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate. 
  • Five-year downstream outcomes following prostate-specific antigen screening in older men. 
  • Gangrene of the penis after implantation of penile prosthesis: case reports, treatment recommendations and review of the literature. 
  • Growth factors for therapeutic angiogenesis in hypercholesterolemic erectile dysfunction. 
  • Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05. 
  • Health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy in the phosphodiesterase type 5 ERA: impact of neurovascular bundle preservation. 
  • Impact of Baseline Total Testosterone Level on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5 mg for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: An Integrated Analysis of Three Randomized Controlled Trials. 
  • Impact of Testosterone Solution 2% on Ejaculatory Dysfunction in Hypogonadal Men. 
  • Impact of phosphodiesterase type 5 inhibitor treatment on the rates of sexually transmitted diseases in a Veterans Affairs Medical Center patient population. 
  • Implantable penile venous compression device: initial experience in the chronic canine model. 
  • Implantation of penile prostheses in patients impotent after priapism. 
  • Impotence due to the pelvic steal syndrome: treatment by iliac transluminal angioplasty. 
  • Impotence following pelvic fracture urethral injury: incidence, aetiology and management. 
  • Improved sexual function in three men taking lamotrigine for epilepsy. 
  • Inflatable Penile Prosthesis: Considerations in Revision Surgery. 
  • Inflatable penile prosthesis: effect of device modification on functional longevity. 
  • Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. 
  • Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose. 
  • Late hematogenous infection of penile prostheses. 
  • Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate. 
  • Long-term results with vacuum constriction device. 
  • Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). 
  • Male sexual dysfunction--the new millennium. 
  • Managing the patient with peripheral neuropathy. 
  • Medical problems occurring after orthotopic liver transplantation. 
  • Mouse model of erectile dysfunction due to diet-induced diabetes mellitus. 
  • Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy. 
  • Negative pressure devices in the explanted penile prosthesis population. 
  • Newer pharmacologic alternatives for erectile dysfunction. 
  • Newer phosphodiesterase inhibitors: comparison with established agents. 
  • Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. 
  • Nitric oxide-releasing polymeric microspheres improve diabetes-related erectile dysfunction. 
  • Obesity does not adversely affect health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy. 
  • Office treatment of male sexual dysfunction. 
  • On statistical analysis for placebo-challenging designs in clinical trials. 
  • On-demand use of erectile aids in men with preoperative erectile dysfunction treated by whole gland prostate cryoablation. 
  • Penile prosthesis for impotence in multiple sclerosis. 
  • Penile prosthesis in Peyronie's disease. 
  • Pfizer to sponsor European impotence awareness campaign. 
  • Pilot Study Evaluating a Rat Model of Radiation-induced Erectile Dysfunction Using an Image-guided Microirradiator. 
  • Predicting low testosterone in aging men: a systematic review. 
  • Prevalence of erectile dysfunction in men screened for prostate cancer. 
  • Prospective analysis of ejaculatory function after anterior urethral reconstruction. 
  • Prospective analysis of erectile dysfunction after anterior urethroplasty: incidence and recovery of function. 
  • Prostate weight and early potency in robot-assisted radical prostatectomy. 
  • Prostate-Confined Radiation Decreased Pelvic Ganglia Neuronal Survival and Outgrowth. 
  • Prostatomembranous urethral injuries: a review of the literature and a rational approach to their management. 
  • Quality of life effects of alprostadil therapy for erectile dysfunction: results of a trial in Europe and South Africa. 
  • Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy. 
  • Radiation-induced erectile dysfunction using prostate-confined modern radiotherapy in a rat model. 
  • Re: The development of erectile dysfunction in men treated for prostate cancer. 
  • Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials. 
  • Recovery of sexual function after prostate cancer treatment. 
  • Relationship between diabetic retinopathy, diabetic macular oedema and erectile dysfunction in type 2 diabetics. 
  • Role of oxidative stress in a rat model of radiation-induced erectile dysfunction. 
  • Sexual Quality of Life and Satisfaction With Penile Prostheses. 
  • Sexual functioning and obesity: a review. 
  • Special concerns for survivors of prostate cancer. 
  • Surgical correction of Peyronie's disease: the Nesbit procedure. 
  • Symptom and function profiles of men with localized prostate cancer. 
  • Systemic basic fibroblast growth factor induces favorable histological changes in the corpus cavernosum of hypercholesterolemic rabbits. 
  • Technological Improvements in Three-Piece Inflatable Penile Prosthesis Design over the Past 40 Years. 
  • The Association between Phosphodiesterase Type 5 Inhibitors and Prostate Cancer: Results from the REDUCE Study. 
  • The Evolution of the Inflatable Penile Prosthesis Reservoir and Surgical Placement. 
  • The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation. 
  • The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study. 
  • The association between sexual function and prostate cancer risk in US veterans. 
  • The association of exercise with both erectile and sexual function in black and white men. 
  • The combined intracavernous injection and stimulation test: diagnostic accuracy. 
  • The development of erectile dysfunction in men treated for prostate cancer. 
  • The prevalence of periodic limb movements during sleep in men with erectile dysfunction. 
  • The relationship of retinal vessel caliber with erectile dysfunction in patients with type 2 diabetes. 
  • Urological and behavioral approach to the treatment of secondary impotence. 
  • Urological and behavioral approach to the treatment of secondary impotence. 
  • Use of glycosylated hemoglobin to identify diabetics at high risk for penile periprosthetic infections. 
  • Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee. 
  • [alpha1-adrenoceptor antagonists and ejaculation dysfunction]. 
• 

  Keywords of People

  • Koontz, Bridget Fey, Associate Professor of Radiation Oncology, Radiation Oncology